Community Health Worker Program for Colorectal Cancer and Cardiovascular Disease
(CHURCH Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on lifestyle changes and community health worker support.
What data supports the effectiveness of the treatment Referral as Usual (RAU), Referral as Usual, Usual Care, SBIRT, Screening, Brief Intervention, and Referral to Treatment for colorectal cancer and cardiovascular disease?
The research highlights the importance of community-based interventions and multidisciplinary approaches in improving screening and prevention for colorectal cancer and cardiovascular disease. These strategies can enhance early detection and management, potentially improving health outcomes for patients with these conditions.12345
Is the Community Health Worker Program for Colorectal Cancer and Cardiovascular Disease safe for humans?
The research articles provided do not contain specific safety data for the Community Health Worker Program or related interventions like Referral as Usual, Usual Care, or SBIRT. However, these types of programs generally focus on education and navigation support, which are typically safe for participants.678910
How does the SBIRT treatment differ from other treatments for colorectal cancer and cardiovascular disease?
SBIRT is unique because it involves community health workers providing education and support to increase awareness and adherence to screening for colorectal cancer, rather than focusing on direct medical interventions. This approach emphasizes outreach and education, particularly in underserved communities, to improve health outcomes.711121314
What is the purpose of this trial?
The overall goal of this study is to develop a comprehensive, culturally tailored community-based colorectal cancer (CRC) prevention model with a dual emphasis on reducing CRC risk along with its CVD risk factors. The study intervention has two components: Screening, Brief Intervention, and Referral to Treatment (SBIRT) to address CRC screening and a web-based lifestyle program called "Alive!" to address CVD risk factors linked to CRC. The C.H.U.R.C.H. Trial (Community Health workers (CHW) United to Reduce Colorectal cancer and cardiovascular disease among people at Higher risk) has four specific aims: (1) to compare the effect of a CHW-Led SBIRT (Intervention) to Referral As Usual (RAU) (Usual Care) on guideline-concordant CRC screening uptake; (2) to evaluate the effect of a Culturally Adapted CHW-linked Alive! (CACA) program incorporated into the intervention arm on dietary inflammatory score (DIS); (3) to evaluate the effect of CACA on changes in Life Simple-7 (LS7) scores; and (4) to examine the multi-level contextual mechanisms and factors influencing CHW effectiveness, reach, and implementation of CRC screening uptake and CACA activities through a mixed-methods process evaluation. Given the broad reach and influence of Black churches, results from this study can be used to inform future scale up of this multi-pronged intervention.
Research Team
Olajide A. Williams, MD, MS
Principal Investigator
Columbia University
Eligibility Criteria
This trial is for English-speaking Black individuals aged 45 and older who are not current with colorectal cancer (CRC) screenings, have a working telephone, and can provide informed consent. There are no specific exclusion criteria listed.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive the SBIRT intervention, including Screening, Brief Intervention, and Referral to Treatment, along with the culturally-adapted Alive! program for lifestyle coaching.
Follow-up
Participants are monitored for CRC screening uptake and changes in dietary and cardiovascular health scores.
Treatment Details
Interventions
- Referral as Usual (RAU)
- SBIRT
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator